Journal article
Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials
Abstract
BackgroundHormone therapy plus radiotherapy significantly decreases recurrences and mortality of patients affected by locally advanced prostate cancer. In order to determine if difference exists according to the hormonal treatment duration, a literature-based meta-analysis was performed.MethodsRelative risks (RR) were derived through a random-effect model. Differences in primary (biochemical failure, BF; cancer-specific survival, CSS), and …
Authors
Cuppone F; Bria E; Giannarelli D; Vaccaro V; Milella M; Nisticò C; Ruggeri EM; Sperduti I; Bracarda S; Pinnarò P
Journal
BMC Cancer, Vol. 10, No. 1,
Publisher
Springer Nature
Publication Date
December 2010
DOI
10.1186/1471-2407-10-675
ISSN
1471-2407
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Antineoplastic Agents, HormonalChemotherapy, AdjuvantDisease-Free SurvivalDrug Administration ScheduleEvidence-Based MedicineHumansMaleNeoplasm Recurrence, LocalNeoplasm StagingProstatic NeoplasmsRadiotherapy, AdjuvantRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsSurvival AnalysisTime FactorsTreatment Outcome